Your browser is no longer supported. Please, upgrade your browser.
Settings
BLUE bluebird bio, Inc. daily Stock Chart
BLUE [NASD]
bluebird bio, Inc.
Index- P/E- EPS (ttm)-11.99 Insider Own0.30% Shs Outstand55.17M Perf Week-11.09%
Market Cap5.89B Forward P/E- EPS next Y-13.06 Insider Trans-27.37% Shs Float54.99M Perf Month-23.79%
Income-654.70M PEG- EPS next Q-3.47 Inst Own- Short Float13.65% Perf Quarter-13.15%
Sales56.50M P/S104.19 EPS this Y-5.30% Inst Trans0.60% Short Ratio13.21 Perf Half Y-28.82%
Book/sh29.66 P/B3.60 EPS next Y3.00% ROA-29.90% Target Price169.88 Perf Year-33.97%
Cash/sh22.73 P/C4.69 EPS next 5Y- ROE-35.90% 52W Range87.49 - 176.55 Perf YTD7.57%
Dividend- P/FCF- EPS past 5Y-39.60% ROI-28.10% 52W High-39.56% Beta2.23
Dividend %- Quick Ratio8.00 Sales past 5Y22.00% Gross Margin- 52W Low21.97% ATR5.15
Employees929 Current Ratio8.00 Sales Q/Q68.40% Oper. Margin- RSI (14)30.98 Volatility4.79% 4.11%
OptionableYes Debt/Eq0.00 EPS Q/Q-21.90% Profit Margin- Rel Volume1.61 Prev Close109.69
ShortableYes LT Debt/Eq0.00 EarningsAug 01 Payout- Avg Volume568.17K Price106.71
Recom2.10 SMA20-13.23% SMA50-15.75% SMA200-17.59% Volume915,089 Change-2.72%
Aug-12-19Downgrade William Blair Outperform → Mkt Perform
Jun-18-19Upgrade Maxim Group Hold → Buy $160
May-15-19Downgrade Wedbush Outperform → Neutral $166 → $131
Mar-05-19Downgrade SVB Leerink Outperform → Mkt Perform
Feb-22-19Reiterated Cantor Fitzgerald Neutral $134 → $122
Dec-20-18Initiated Raymond James Strong Buy $165
Dec-06-18Downgrade Piper Jaffray Overweight → Neutral
Nov-14-18Upgrade Bernstein Mkt Perform → Outperform
Nov-05-18Upgrade Janney Neutral → Buy
Nov-02-18Upgrade Cantor Fitzgerald Underweight → Neutral $122 → $134
Jul-12-18Initiated Gabelli & Co Buy $239
Jun-19-18Upgrade Evercore ISI In-line → Outperform
Mar-21-18Reiterated Morgan Stanley Equal-Weight $152 → $209
Mar-14-18Initiated Janney Neutral
Mar-05-18Initiated William Blair Outperform
Feb-22-18Reiterated Cantor Fitzgerald Underweight $122 → $113
Jan-25-18Downgrade Leerink Partners Outperform → Mkt Perform
Dec-21-17Initiated Oppenheimer Perform
Dec-13-17Reiterated Barclays Overweight $162 → $209
Dec-13-17Downgrade Maxim Group Buy → Hold $200
Aug-22-19 04:05PM  bluebird bio Announces Investor Events in September Business Wire -7.29%
02:18AM  Massachusetts-based biotech company opens office in Eastlake neighborhood (Photos) American City Business Journals
Aug-16-19 06:20AM  Gene therapies to test FDA's approach to regulating drugs after launch, experts say American City Business Journals
Aug-12-19 04:16PM  Why This Biotech's $1.8 Million Gene Therapy Could Be A 'Slow Mover' Investor's Business Daily -5.25%
10:30AM  Bluebird Bio Stock Down as Analyst Raises Worries About Zynteglo Launch Barrons.com
07:38AM  Bluebird Bio Drops Following William Blair Downgrade TheStreet.com
Aug-08-19 10:25AM  Did bluebird bio, Inc. (NASDAQ:BLUE) Insiders Sell Shares? Simply Wall St.
Aug-07-19 05:30PM  bluebird bio Prepares for Launch Motley Fool
Aug-02-19 11:12AM  bluebird's (BLUE) Loss Wider Than Expected, Revenues Beat Zacks -6.14%
Aug-01-19 07:45PM  Bluebird Bio (BLUE) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:36PM  bluebird bio Reports Second Quarter 2019 Financial Results and Highlights Operational Progress Business Wire
Jul-25-19 10:33AM  Analysts Estimate Bluebird Bio (BLUE) to Report a Decline in Earnings: What to Look Out for Zacks
Jul-15-19 02:46PM  Biotech investors Wellington, RA Capitals new funds top $700 million American City Business Journals
Jul-10-19 05:43AM  JP Morgan: 2 Gene Therapy Stocks to Buy Now TipRanks
Jul-09-19 01:58PM  5 Immunotherapy Stocks to Keep a Close Eye On GuruFocus.com
Jul-07-19 12:13PM  Is bluebird bio a Buy? Motley Fool
Jul-02-19 11:53AM  Marshall Waces Return, AUM, and Holdings (Part II) Insider Monkey
Jun-21-19 08:00AM  Where Will bluebird bio Be in 1 Year? Motley Fool
Jun-18-19 04:14PM  Why This Biotech's Approved Gene Therapy Won't Launch Until 2020 Investor's Business Daily
09:53AM  Bluebird Bio Stock Rises on Analysts Buy Call Barrons.com
Jun-17-19 07:17PM  Is bluebird bio Inc (BLUE) A Good Stock To Buy? Insider Monkey
Jun-15-19 05:00PM  Is $1.8 Million for bluebird bio's New Gene Therapy Ridiculous? Motley Fool
Jun-14-19 04:00PM  Bluebird Bios Gene Therapy Is $1.8 Million Per Patient. The Stock Is Falling. Barrons.com -5.07%
08:54AM  Bluebird prices gene therapy in Europe at $1.8M over 5 years American City Business Journals
05:31AM  bluebird bio Presents New Data for LentiGlobin® Gene Therapy for Sickle Cell Disease (SCD) at 24th European Hematology Association (EHA) Congress Business Wire
05:31AM  bluebird bio Presents Long-Term Efficacy and Safety Data from Clinical Studies of LentiGlobin® Gene Therapy for Transfusion-Dependent -Thalassemia (TDT) at 24th European Hematology Association (EHA) Congress Business Wire
Jun-13-19 10:35PM  Bluebird Bio prices gene therapy at nearly $1.8m Financial Times +5.52%
09:08PM  Chicago biotech sues Third Rock, bluebird bio CEO over gene therapy license American City Business Journals
Jun-12-19 12:14PM  bluebird bio (NASDAQ:BLUE) Shareholders Have Enjoyed An Impressive 223% Share Price Gain Simply Wall St.
Jun-06-19 05:04PM  bluebird bio Announces Live Webcast of EHA Data Review and ZYNTEGLO® (autologous CD34+ cells encoding A-T87Q-globin gene) Approval Business Wire
09:17AM  Life sciences VC firm Third Rock raises $770M in its largest round ever American City Business Journals
Jun-04-19 04:16PM  bluebird's Zynteglo Gets EU Conditional Marketing Approval Zacks +5.73%
03:31PM  It's Official: bluebird bio Gets a Green Light for Game-Changing Gene Therapy Motley Fool
Jun-03-19 09:25AM  bluebird bio Announces EU Conditional Marketing Authorization for ZYNTEGLO (autologous CD34+ cells encoding A-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent -Thalassemia Who Do Not Have 0/0 Genotype Business Wire
Jun-01-19 09:31AM  Why Is Bluebird (BLUE) Down 15.1% Since Last Earnings Report? Zacks
May-31-19 08:00AM  bluebird bio Announces Investor Events in June Business Wire
May-30-19 02:34PM  Save the Date: 11 Biotech Stocks to Put on Your Radar Kiplinger
May-25-19 12:30PM  Marshall Waces Latest Moves Insider Monkey
May-19-19 07:00AM  Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big Motley Fool
May-16-19 09:12AM  bluebird bio to Present New Data from Clinical Studies of LentiGlobin Gene Therapy for Transfusion-Dependent -thalassemia (TDT) and LentiGlobin Gene Therapy for Sickle Cell Disease (SCD) at the 24th EHA Congress Business Wire
May-15-19 02:10PM  Bluebird Bio's Near-Term Product Launches Pose Risks, Wedbush Says In Downgrade Benzinga
10:49AM  Bluebird Bios Pricing Plan Worries One Biotech Analyst. Heres Why. Barrons.com
May-09-19 06:30AM  bluebird bios Analyst Day Highlights Commercial Path to Patients and Research Engine Focused on Next-Generation Gene and Cell Therapies Business Wire
May-08-19 08:12AM  bluebird bio Flies Forward Motley Fool
May-06-19 11:50AM  bluebird's (BLUE) Loss Wider Than Expected, Revenues Down Y/Y Zacks
May-03-19 08:00AM  bluebird bio Announces Investor Events in May Business Wire
May-02-19 06:45PM  Bluebird Bio (BLUE) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:40PM  Bluebird: 1Q Earnings Snapshot Associated Press
04:05PM  bluebird bio Reports First Quarter 2019 Financial Results and Highlights Operational Progress Business Wire
May-01-19 05:01PM  Celgene Corporation and bluebird bio Announce Results from Ongoing Multicenter Phase 1 Study of bb2121 anti-BCMA CAR T Cell Therapy in Patients with Multiple Myeloma Published in New England Journal of Medicine Business Wire
08:00AM  bluebird bio Appoints Joanne Smith-Farrell, Ph.D., to Chief Business Officer Business Wire
Apr-30-19 03:18PM  5 Biotech Stocks for a Long-Lived Portfolio InvestorPlace
09:15AM  Small Gains Still Bring New Highs Zacks
Apr-29-19 08:01AM  20 High-Growth Stocks For The Next 20 Years Motley Fool
Apr-28-19 10:47PM  Is a Beat in the Cards for Molina's (MOH) Earnings in Q1? Zacks
Apr-27-19 07:33AM  How a Medicare Rule Change Could Bring CAR-T Stocks Back to Life Motley Fool
Apr-26-19 11:48AM  Universal Health (UHS) Q1 Earnings, Revenues Miss Estimates Zacks
11:42AM  What's in Store for HCA Healthcare's (HCA) Q1 Earnings? Zacks
11:38AM  Is a Beat in Store for WellCare Health's (WCG) Q1 Earnings? Zacks
Apr-25-19 02:20PM  Why bluebird bio, Inc.'s (NASDAQ:BLUE) CEO Pay Matters To You Simply Wall St.
11:55AM  Tenet Healthcare (THC) to Post Q1 Earnings: What's in Store? Zacks
Apr-24-19 11:25AM  Anthem's (ANTM) Q1 Earnings Beat Estimates, Improve Y/Y Zacks
10:33AM  Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: Should You Buy? Zacks
05:46AM  Ahead of 1st drug approval, bluebird CEO's pay triples to $24M American City Business Journals
Apr-23-19 06:20PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Breaches of Fiduciary Duty by the Certain Officers and Directors of bluebird bio, Inc. ACCESSWIRE
Apr-22-19 03:09PM  Did Hedge Funds Drop The Ball On bluebird bio Inc (BLUE) ? Insider Monkey
01:54PM  This Is Why You Shouldnt Count Regeneron Stock Out InvestorPlace
Apr-19-19 02:48PM  Top Gene-Sequencing Stocks for 2019 Motley Fool
Apr-18-19 02:45PM  Cambridge's bluebird bio expanding Kendall Square HQ American City Business Journals
Apr-17-19 05:15PM  Here's Why Shares of bluebird bio Slumped Today Motley Fool -9.50%
Apr-15-19 02:00PM  Four Companies Could Power The New Genomics ETF ETF Trends
Apr-09-19 10:52AM  Why bluebird bio Could Deliver Miracles to Genetic Disease Patients Motley Fool
09:53AM  5 Stocks in the Age of Miracles Motley Fool
Apr-08-19 06:11PM  Celgene & Acceleron Submit BLA for Luspatercept to the FDA Zacks
Apr-07-19 09:05AM  3 High-Growth Genomics Stocks You Can Buy Motley Fool
Mar-31-19 11:01AM  2 Blockbuster Gene Therapy Programs to Watch in 2019 Motley Fool
Mar-29-19 07:47AM  EMA panel recommends approval of Bluebird Bio's first gene therapy Reuters
07:44AM  bluebird bio Receives Positive Opinion from CHMP for ZYNTEGLO (autologous CD34+ cells encoding A-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent -Thalassemia (TDT) Who Do Not Have 0/0 Genotype Business Wire
07:36AM  EMA panel recommends approval of Bluebird Bio's first gene therapy Reuters
Mar-26-19 05:15PM  Celgene (CELG) Submits NDA for MS Drug to FDA for Review Zacks
Mar-25-19 08:24AM  Massachusetts concern details plan to hire new workers in Durham American City Business Journals
Mar-23-19 09:30AM  Why Is Bluebird (BLUE) Up 15.3% Since Last Earnings Report? Zacks
Mar-22-19 08:00AM  bluebird bio Opens State-of-the-Art Gene and Cell Therapy Manufacturing Facility in Durham, North Carolina Business Wire -6.11%
Mar-12-19 10:07AM  Celgene (CELG) Submits Application for MS Drug in Europe Zacks
Mar-11-19 02:28AM  Here's Why bluebird bio Gained 16.3% in February Motley Fool +5.89%
Mar-08-19 08:00AM  bluebird bio to Present at Investor Conferences in March Business Wire
Mar-07-19 12:32PM  What Are Analysts Saying About bluebird bio, Inc.s (NASDAQ:BLUE) Earnings Outlook? Simply Wall St.
Feb-26-19 04:21PM  With a Stocked War Chest, bluebird bio Presses On Motley Fool
11:15AM  Biotech ETFs Jump on Roche-Spark Deal Zacks
Feb-23-19 08:10PM  Better Buy: bluebird bio vs. Gilead Sciences Motley Fool
Feb-22-19 02:46PM  bluebird (BLUE) Q4 Earnings Beat Estimates, Revenues Up Y/Y Zacks
Feb-21-19 07:15PM  Bluebird Bio (BLUE) Reports Q4 Loss, Tops Revenue Estimates Zacks
06:17PM  Bluebird: 4Q Earnings Snapshot Associated Press
04:05PM  bluebird bio Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress Business Wire
Feb-14-19 07:55AM  Report: Exploring Fundamental Drivers Behind Tyson Foods, ElectraMeccanica Vehicles, Cousins Properties, Spirit Aerosystems, bluebird bio, and Yext New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Feb-13-19 10:31AM  Earnings Preview: Bluebird Bio (BLUE) Q4 Earnings Expected to Decline Zacks
Feb-12-19 09:11AM  AbbVie Buys Rights to Novel Immunotherapy for Multiple Myeloma Zacks
Feb-11-19 06:30AM  bluebird bio Appoints Chip Baird as Chief Financial Officer Business Wire
Feb-06-19 01:52PM  Regeneron Q4 Earnings & Sales Beat on Strong Dupixent, Eylea Zacks
Feb-01-19 02:11PM  German firm that serves gene therapy biotechs opens Cambridge HQ American City Business Journals
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on developing transformative gene therapies for severe genetic diseases and cancer. Its product candidates in severe genetic diseases include LentiGlobin, which is in various clinical studies for the treatment of transfusion-dependent ß-thalassemia and severe sickle cell disease; and Lenti-D that is in Phase II/III clinical trials for the treatment of cerebral adrenoleukodystrophy, a rare hereditary neurological disorder. The company's product candidates in oncology include bb2121 and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology; and Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize various immune cell therapies for cancer. The company also has collaborations with Medigene AG to discover T cell receptor (TCR) product candidates in the field of cancer; Gritstone Oncology, Inc. to discover TCR product candidates in the field of cancer; and TC BioPharm Limited to research and develop gamma delta CAR T cells directed at hematologic and solid tumor targets. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Walsh Jeffrey T.Chief Strategy OfficerAug 20Option Exercise24.4750012,23541,421Aug 21 04:06 PM
Walsh Jeffrey T.Chief Strategy OfficerAug 20Sale124.0050062,00040,921Aug 21 04:06 PM
Gregory Philip DChief Scientific OfficerAug 08Option Exercise75.6070052,92031,042Aug 12 04:08 PM
Gregory Philip DChief Scientific OfficerAug 08Sale124.03950117,82430,092Aug 12 04:08 PM
Davidson DavidChief Medical OfficerAug 06Option Exercise50.515,060255,58136,676Aug 08 04:19 PM
Davidson DavidChief Medical OfficerAug 06Sale116.085,060587,38931,616Aug 08 04:19 PM
Gregory Philip DChief Scientific OfficerAug 05Option Exercise50.5160030,30631,192Aug 07 04:14 PM
Gregory Philip DChief Scientific OfficerAug 05Sale116.9385099,39330,342Aug 07 04:14 PM
Davidson DavidChief Medical OfficerJul 05Option Exercise48.577,660372,05339,276Jul 09 04:20 PM
Gregory Philip DChief Scientific OfficerJul 05Option Exercise64.021,30083,22632,392Jul 09 04:22 PM
Davidson DavidChief Medical OfficerJul 05Sale129.477,660991,74831,616Jul 09 04:20 PM
Gregory Philip DChief Scientific OfficerJul 05Sale129.131,800232,42630,592Jul 09 04:22 PM
Walsh Jeffrey T.Chief Strategy OfficerJun 18Option Exercise24.471002,44741,021Jun 20 04:52 PM
Walsh Jeffrey T.Chief Strategy OfficerJun 18Sale126.1210012,61240,921Jun 20 04:52 PM
Walsh Jeffrey T.Chief Strategy OfficerJun 10Option Exercise24.471,40034,25842,321Jun 12 04:31 PM
Walsh Jeffrey T.Chief Strategy OfficerJun 10Sale125.441,400175,61940,921Jun 12 04:31 PM
Davidson DavidChief Medical OfficerJun 06Option Exercise50.515,060255,58136,676Jun 10 04:14 PM
Davidson DavidChief Medical OfficerJun 06Sale122.645,060620,53931,616Jun 10 04:14 PM
Gregory Philip DChief Scientific OfficerJun 05Option Exercise64.021,30083,22632,892Jun 07 04:09 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJun 05Sale127.60617,7846,846Jun 07 04:11 PM
Gregory Philip DChief Scientific OfficerJun 05Sale128.601,800231,48831,092Jun 07 04:09 PM
Walsh Jeffrey T.Chief Strategy OfficerMay 10Option Exercise24.471,50036,70542,421May 14 04:08 PM
Cole JasonChief Operating andMay 10Option Exercise50.5156228,38727,006May 14 04:07 PM
Walsh Jeffrey T.Chief Strategy OfficerMay 10Sale132.301,500198,45040,921May 14 04:08 PM
Davidson DavidChief Medical OfficerMay 06Option Exercise5.506,36034,98337,976May 08 04:35 PM
Gregory Philip DChief Scientific OfficerMay 06Option Exercise64.021,30083,22633,392May 08 04:35 PM
Davidson DavidChief Medical OfficerMay 06Sale138.956,360883,71831,616May 08 04:35 PM
Gregory Philip DChief Scientific OfficerMay 06Sale138.441,800249,18331,592May 08 04:35 PM
Walsh Jeffrey T.Chief Strategy OfficerApr 10Option Exercise24.471,50036,70542,421Apr 12 04:17 PM
Walsh Jeffrey T.Chief Strategy OfficerApr 10Sale156.651,500234,97640,921Apr 12 04:17 PM
Gregory Philip DChief Scientific OfficerApr 05Option Exercise64.021,30083,22633,892Apr 09 04:50 PM
Gregory Philip DChief Scientific OfficerApr 05Sale157.601,800283,68132,092Apr 09 04:50 PM
Davidson DavidChief Medical OfficerApr 04Option Exercise5.506,36034,98337,976Apr 08 04:11 PM
Davidson DavidChief Medical OfficerApr 04Sale160.066,3601,017,97631,616Apr 08 04:11 PM
Davidson DavidChief Medical OfficerMar 13Option Exercise5.503,10117,05734,717Mar 15 04:32 PM
Davidson DavidChief Medical OfficerMar 13Sale146.413,101454,00531,616Mar 15 04:32 PM
Walsh Jeffrey T.Chief Strategy OfficerMar 11Option Exercise24.471,50036,70542,421Mar 13 04:14 PM
Walsh Jeffrey T.Chief Strategy OfficerMar 11Sale139.801,500209,69840,921Mar 13 04:14 PM
Gregory Philip DChief Scientific OfficerMar 05Option Exercise64.021,30083,22634,392Mar 07 04:26 PM
Gregory Philip DChief Scientific OfficerMar 05Sale147.711,800265,87932,592Mar 07 04:26 PM
Davidson DavidChief Medical OfficerMar 04Option Exercise50.514,910248,00436,526Mar 06 04:32 PM
Davidson DavidChief Medical OfficerMar 04Sale155.774,910764,83231,616Mar 06 04:32 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerFeb 28Sale151.71517,7376,695Mar 04 04:34 PM
Cole JasonChief Operating andFeb 25Option Exercise40.446,248252,68732,692Feb 27 04:59 PM
Cole JasonChief Operating andFeb 25Sale150.246,248938,69826,444Feb 27 04:59 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerFeb 25Sale150.0020831,2016,746Feb 27 04:57 PM
Walsh Jeffrey T.Chief Financial andFeb 08Option Exercise24.471,50036,70542,421Feb 12 04:11 PM
Walsh Jeffrey T.Chief Financial andFeb 08Sale131.291,500196,92840,921Feb 12 04:11 PM
Gregory Philip DChief Scientific OfficerFeb 05Option Exercise64.021,30083,22634,892Feb 07 05:21 PM
Gregory Philip DChief Scientific OfficerFeb 05Sale137.991,800248,38333,092Feb 07 05:21 PM
Davidson DavidChief Medical OfficerFeb 04Option Exercise31.664,910155,43236,526Feb 05 05:58 PM
Davidson DavidChief Medical OfficerFeb 04Sale134.304,910659,41731,616Feb 05 05:58 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerJan 28Sale125.9620926,3264,403Jan 30 04:35 PM
Davidson DavidChief Medical OfficerJan 18Option Exercise24.472,03549,79624,276Jan 23 04:18 PM
Davidson DavidChief Medical OfficerJan 18Sale130.052,035264,64422,241Jan 23 04:18 PM
Walsh Jeffrey T.Chief FinancialJan 16Option Exercise24.473,00073,41035,483Jan 18 04:06 PM
Gregory Philip DChief Scientific OfficerJan 16Option Exercise75.601,400105,84028,742Jan 18 04:03 PM
Walsh Jeffrey T.Chief FinancialJan 16Sale125.143,000375,42832,483Jan 18 04:06 PM
Gregory Philip DChief Scientific OfficerJan 16Sale124.251,900236,06926,842Jan 18 04:03 PM
Gregory Philip DChief Scientific OfficerJan 07Option Exercise50.5160030,30631,221Jan 09 04:57 PM
Walsh Jeffrey T.Chief FinancialJan 07Sale113.643,012342,27632,483Jan 09 05:05 PM
Leschly NickPresident and CEOJan 07Sale113.647,374837,966193,203Jan 09 05:03 PM
Gregory Philip DChief Scientific OfficerJan 07Sale112.493,879436,36327,342Jan 09 04:57 PM
FINGER ALISON CECILYChief Commercial OfficerJan 07Sale113.6464373,06814,548Jan 09 04:53 PM
Davidson DavidChief Medical OfficerJan 07Sale113.642,664302,73422,241Jan 09 04:46 PM
Cole JasonChief Legal OfficerJan 07Sale113.641,416160,91420,194Jan 09 04:39 PM
Davidson DavidChief Medical OfficerJan 03Option Exercise24.471002,44725,005Jan 04 04:17 PM
FINGER ALISON CECILYChief Commercial OfficerJan 03Sale99.3142842,50615,239Jan 07 04:39 PM
Davidson DavidChief Medical OfficerJan 03Sale100.3210010,03224,905Jan 04 04:17 PM
Davidson DavidChief Medical OfficerJan 02Option Exercise17.397,500130,41029,605Jan 04 04:17 PM
Davidson DavidChief Medical OfficerJan 02Sale98.807,500741,02824,905Jan 04 04:17 PM
WENTWORTH KORY JAMESPrincipal Accounting OfficerDec 19Sale103.0538839,9834,612Dec 21 04:26 PM
Gregory Philip DChief Scientific OfficerDec 06Option Exercise50.5160030,30631,471Dec 10 04:09 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 06Sale105.711,875198,19813,735Dec 10 04:11 PM
Gregory Philip DChief Scientific OfficerDec 06Sale106.5685090,57730,621Dec 10 04:09 PM
Davidson DavidChief Medical OfficerDec 04Option Exercise5.502,00011,00126,905Dec 06 04:12 PM
Davidson DavidChief Medical OfficerDec 04Sale121.052,000242,10824,905Dec 06 04:12 PM
Davidson DavidChief Medical OfficerDec 03Option Exercise5.506,00033,00230,905Dec 06 04:12 PM
HIGH SUSANNA GATTIChief Operating OfficerDec 03Sale113.831,890215,13515,610Dec 06 04:14 PM
Davidson DavidChief Medical OfficerDec 03Sale113.596,000681,53824,905Dec 06 04:12 PM
Walsh Jeffrey T.Chief FinancialNov 09Option Exercise24.471,50036,70536,995Nov 14 04:10 PM
Walsh Jeffrey T.Chief FinancialNov 09Sale130.591,500195,89135,495Nov 14 04:10 PM
Gregory Philip DChief Scientific OfficerNov 05Option Exercise64.021,30083,22632,671Nov 07 04:14 PM
Gregory Philip DChief Scientific OfficerNov 05Sale137.381,800247,27730,871Nov 07 04:14 PM
Davidson DavidChief Medical OfficerNov 02Option Exercise5.505,00027,50229,905Nov 06 04:15 PM
Davidson DavidChief Medical OfficerNov 02Sale133.645,000668,21624,905Nov 06 04:15 PM
Walsh Jeffrey T.Chief FinancialOct 10Option Exercise24.471,50036,70536,995Oct 12 04:53 PM
Walsh Jeffrey T.Chief FinancialOct 10Sale135.231,500202,83935,495Oct 12 04:53 PM
Gregory Philip DChief Scientific OfficerOct 05Option Exercise64.021,30083,22633,171Oct 10 04:17 PM
Gregory Philip DChief Scientific OfficerOct 05Sale140.561,800253,00031,371Oct 10 04:17 PM
Davidson DavidChief Medical OfficerOct 02Option Exercise5.505,00027,50229,905Oct 04 04:21 PM
Davidson DavidChief Medical OfficerOct 02Sale139.325,000696,58824,905Oct 04 04:21 PM
Walsh Jeffrey T.Chief FinancialSep 10Option Exercise24.471,50036,70536,995Sep 12 04:12 PM
Walsh Jeffrey T.Chief FinancialSep 10Sale150.161,500225,24335,495Sep 12 04:12 PM
Mandell JamesDirectorSep 10Sale150.771,000150,7711,000Sep 12 04:07 PM
Gregory Philip DChief Scientific OfficerSep 05Option Exercise64.021,30083,22633,671Sep 07 04:32 PM
Gregory Philip DChief Scientific OfficerSep 05Sale163.021,800293,44131,871Sep 07 04:32 PM
Davidson DavidChief Medical OfficerSep 04Option Exercise5.507,00038,50331,905Sep 06 04:12 PM
Davidson DavidChief Medical OfficerSep 04Sale166.647,0001,166,49324,905Sep 06 04:12 PM
Walsh Jeffrey T.Chief FinancialAug 30Option Exercise10.8820,000217,68955,495Sep 04 05:03 PM